Canada
· Delayed Price · Currency is CAD CSE: MUSL Statistics
Total Valuation
Promino Nutritional Sciences has a market cap or net worth of CAD 5.16 million. The enterprise value is 5.79 million.
| Market Cap | 5.16M |
| Enterprise Value | 5.79M |
Important Dates
The next estimated earnings date is Friday, May 2, 2025.
| Earnings Date | May 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Promino Nutritional Sciences has 114.58 million shares outstanding. The number of shares has decreased by -92.01% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 114.58M |
| Shares Change (YoY) | -92.01% |
| Shares Change (QoQ) | +54.13% |
| Owned by Insiders (%) | 1.11% |
| Owned by Institutions (%) | n/a |
| Float | 113.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.41 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.50 |
| EV / Sales | 23.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.53
| Current Ratio | 0.53 |
| Quick Ratio | 0.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.93 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -281.38% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.09 |
| Inventory Turnover | 0.84 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.00% in the last 52 weeks. The beta is 2.62, so Promino Nutritional Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.62 |
| 52-Week Price Change | -75.00% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.13 |
| Relative Strength Index (RSI) | 43.03 |
| Average Volume (20 Days) | 142,294 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Promino Nutritional Sciences had revenue of CAD 246,078 and -11.58 million in losses. Loss per share was -1.51.
| Revenue | 246,078 |
| Gross Profit | -742,223 |
| Operating Income | -12.16M |
| Pretax Income | -11.58M |
| Net Income | -11.58M |
| EBITDA | -12.14M |
| EBIT | -12.16M |
| Loss Per Share | -1.51 |
Balance Sheet
The company has 1.08 million in cash and 1.72 million in debt, giving a net cash position of -634,319 or -0.01 per share.
| Cash & Cash Equivalents | 1.08M |
| Total Debt | 1.72M |
| Net Cash | -634,319 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -3.74M |
| Book Value Per Share | -0.03 |
| Working Capital | -2.61M |
Cash Flow
| Operating Cash Flow | -3.08M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -4,943.30% |
| Pretax Margin | -4,707.82% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Promino Nutritional Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 92.01% |
| Shareholder Yield | 92.01% |
| Earnings Yield | -3,346.25% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on April 1, 2024. It was a reverse split with a ratio of 0.3333333.
| Last Split Date | Apr 1, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.3333333 |
Scores
Promino Nutritional Sciences has an Altman Z-Score of -35.84. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -35.84 |
| Piotroski F-Score | n/a |